Empagliflozin attenuates sorafenib-promoted renal ferroptosis and inflammation by targeting cyclooxygenase-2/prostaglandin E₂ axis.

Empagliflozin 透過調控 cyclooxygenase-2/prostaglandin E₂ 軸，減緩 sorafenib 促進的腎臟 ferroptosis 與發炎反應